CD44 and cancer: HA, a primary CD44 ligand and extracellular matrix component can thus promote cancer invasion [25, 41], and may play a similar role in EC where its increased expression, particularly near neoplastic infiltration, correlates with depth of myometrial invasion, low disease grade and LVSI [25, 37, 41].